3Dellinger RP, Levy MM, Cadet JM, et al. Surviving sepsis campaign : International guidelines for management of severe sepsis and septic shock : 2008 [ J ]. Crit Care Med,2008,36 ( 1 ) :296 - 327.
4Kumar A. Optimizing antimicrobial therapy in sepsis and septic shock [J]. Crit Care Clin, 2009,25 (4) :733 - 751.
5Kung HC, Hoyert DL, Xu J, et al. Deaths: Final data for 2005 [ J]. Natl Vital Stat Rep, 200g ,56(10) :1 - 120.
6Macarthur RD, Miller M, Albertson T, et aL Adequacy of early empiric antibiotic treatment and survival in severe sepsis: Experience from the MONARCS trial[ J]. Clin lnfect Dis,2004,38 (2) :284 -288.
7Deresinski S. Principles of antibiotic therapy in severe infections: Opti- mizing the therapeutic approach by use of laboratory and clinical data [ J ]. Clin Infect Dis,2007,45 (suppl 3 ) :177 - 183.
8Rojas MX, Granados C. Oral antibiotics versus parenteral antibiotics for severe pneumonia in children [ J ]. Cochrane Database Syst Rev, 2006 ( 2 ) : CD004979.
9Mccracken GH Jr. New era for orally administered antibiotics : Use of se- quential parenteral - oral antibiotic therapy for serious infectious disea- ses of infants and children[ J]. Pediatr Infect Dis J, 1987,6(10) :951 - 953.
10American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital - acquired, ventilator - associated, and healthcare - associated pneumonia [ J ]. Ant J Respir Crit Care Meal,2005,171 (4) :388 -416.
